Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
28,208
Sort by:
Global Anti-Fungal Drugs Market, By Drug Class (Azoles, Echinocandins, Polyenes, Allylamines, Others), By Indication (Candidiasis, Aspergillosis, Mucormycosis, Dermatophytosis, Others), By Infection Type (Superficial Fungal Infection, Systemic Fungal Infection), By Route of Administration (Topical, Oral, Parenteral, Others), By End User (Homecare, Hospitals, Clinics, Others) By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy), By Region, Competition Forecast & Opportunities, 2026
US$ 4,500.00
Global anti-fungal drugs market is expected to reach USD28484.69 million by 2026, growing at CAGR of 10.39% over the forecast period. Fungal infections can lead to diseases including fungal pneumonia,...
October 2021
114 pages
Acute Graft-versus-Host Disease - Pipeline Insight, 2021
US$ 2,000.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Acute Graft-versus-Host Disease - Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and...
October 2021
60 pages
Chikungunya virus infections - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Chikungunya virus infections - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10...
October 2021
60 pages
Medical Marijuana - Cannabidiol – Pipeline Insight, 2021
US$ 2,500.00
This report can be delivered to the clients within 3-4 Business Days DelveInsight’s, “Medical Marijuana - Cannabidiol – Pipeline Insight, 2021,” report provides comprehensive insights about 25+ comp...
October 2021
60 pages
Natural Killer Cell Therapies - Pipeline Insight, 2021
US$ 3,000.00
This report can be delivered to the clients within 7-10 Business Days DelveInsight’s, “Natural Killer Cell Therapies - Pipeline Insight, 2021,” report provides comprehensive insights about 100+ comp...
October 2021
300 pages
Stomatitis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 hours DelveInsight’s, “Stomatitis – Pipeline Insight, 2021,” report provides comprehensive insights about 15+ companies and 15+ pipeline drug...
October 2021
60 pages
TCR therapy - Pipeline Insight, 2021
US$ 2,000.00
This report can be delivered to the clients within 3-5 business days DelveInsight’s, “TCR therapy – Pipeline Insight, 2021,” report provides comprehensive insights about 25+ companies and 35+ pipeli...
October 2021
60 pages
Zika Virus Infection - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Zika Virus Infection - Pipeline Insight, 2021,” report provides comprehensive insights about 12+ companies and 12+ pipeli...
October 2021
60 pages
Anti CD47 Drugs Market by Target Disease Indication (Acute Myeloid Leukemias, Non-Hodgkin Lymphoma, Colorectal Cancers, Diffuse Large B-cell Lymphoma, Myelodysplastic Syndromes, Non-Small Cell Lung Cancers, Ovarian Epithelial Cancer, Oral Muscositis, Small Cell Lung Cancers), Type of Molecule (Biologics and Small Molecule) Key Players and Key Geographical Regions (US, France, Germany, Italy, Spain, UK, Australia, China, India and Israel): Industry Trends and Global Forecasts, 2021-2035
US$ 4,799.00
The anti CD47 market is expected to reach USD 0.1 billion in 2023 and anticipated to grow at a CAGR of 42.9% during the forecast period 2021-2035. According to the World Health Organization (WHO), can...
October 2021
178 pages
20s Proteasome - Drugs in Development, 2021
US$ 3,500.00
20s Proteasome - Drugs in Development, 2021 SUMMARY 20s Proteasome pipeline Target constitutes close to 9 molecules. Out of which approximately 6 molecules are developed by companies and remaining by...
September 2021
76 pages
Anaphylaxis (Immunology) - Drugs in Development, 2021
US$ 2,000.00
Anaphylaxis (Immunology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anaphylaxis - Drugs In Development, 2021, provides an...
September 2021
67 pages
Aplastic Anemia (Hematology) - Drugs in Development, 2021
US$ 2,000.00
Aplastic Anemia (Hematology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Aplastic Anemia - Drugs In Development, 2021, prov...
September 2021
138 pages
Diphtheria (Infectious Disease) - Drugs in Development, 2021
US$ 2,000.00
Diphtheria (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diphtheria - Drugs In Development, 2021, provid...
September 2021
93 pages
Fanconi Anemia (Hematology) - Drugs in Development, 2021
US$ 2,000.00
Fanconi Anemia (Hematology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fanconi Anemia - Drugs In Development, 2021, provid...
September 2021
93 pages
Gastritis (Gastrointestinal) - Drugs in Development, 2021
US$ 2,000.00
Gastritis (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastritis - Drugs In Development, 2021, provides a...
September 2021
99 pages
Glycoprotein 41 (gp41) - Drugs in Development, 2021
US$ 3,500.00
Glycoprotein 41 (gp41) - Drugs in Development, 2021 SUMMARY According to the recently published report 'Glycoprotein 41 - Drugs In Development, 2021'; Glycoprotein 41 (gp41) pipeline Target constitute...
September 2021
67 pages
Impetigo (Infectious Disease) - Drugs in Development, 2021
US$ 2,000.00
Impetigo (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Impetigo - Drugs In Development, 2021, provides a...
September 2021
45 pages
Malaria (Infectious Disease) - Drugs in Development, 2021
US$ 2,500.00
Malaria (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Malaria - Drugs In Development, 2021, provides an...
September 2021
450 pages
Pemphigus Vulgaris (Immunology) - Drugs in Development, 2021
US$ 2,000.00
Pemphigus Vulgaris (Immunology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pemphigus Vulgaris - Drugs In Development, 2021...
September 2021
88 pages
Peritonitis (Gastrointestinal) - Drugs in Development, 2021
US$ 2,000.00
Peritonitis (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peritonitis - Drugs In Development, 2021, provid...
September 2021
53 pages
